Of note, the lack of any significant impact by vehicle intake on endothelial dysfunction in MeCP2+/− mice rules out any active role played by the natural progression of the disease and the observed beneficial effects can thus be attributed to the pharmacological treatment, at least in the specific time period investigated. This evidence concerns the gene MECP2 and endothelial dysfunction.